Show simple item record

dc.contributor.authorMazoteras-Pardo, Victoria
dc.contributor.authorBecerro-de-Bengoa-Vallejo, Ricardo
dc.contributor.authorLosa Iglesias, Marta Elena
dc.contributor.authorLópez-López, Daniel
dc.contributor.authorRodríguez Sanz, David
dc.contributor.authorCasado-Hernández, Israel
dc.contributor.authorCalvo-Lobo, César
dc.contributor.authorPalomo-López, Patricia
dc.date.accessioned2020-01-02T16:54:35Z
dc.date.available2020-01-02T16:54:35Z
dc.date.issued2019-12
dc.identifier.citationMazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, López-López D, Rodríguez-Sanz D, Casado-Hernández I, Calvo-Lobo C, Palomo-López P QardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease: A Validation Study According to the European Society of Hypertension International Protocol Revision 2010 J Med Internet Res 2019;21(12):e14686 DOI: 10.2196/14686 PMID: 31789600es_ES
dc.identifier.issn1438-8871
dc.identifier.urihttp://hdl.handle.net/2183/24562
dc.description.abstract[Abstract] Background: Hypertension is considered as a main risk factor for chronic kidney disease development and progression. Thus, the control and evaluation of this disease with new software and devices are especially important in patients who suffer from chronic kidney disease. Objective: This study aimed to validate the QardioArm mobile device, which is used for blood pressure (BP) self-measurement in patients who suffer from chronic kidney disease, by following the European Society of Hypertension International Protocol 2 (ESH-IP2) guidelines. Methods: A validation study was carried out by following the ESH-IP2 guidelines. A sample of 33 patients with chronic kidney disease self-measured their BP by using the QardioArm and Omron M3 Intellisense devices. Heart rate (HR), diastolic BP, and systolic BP were measured. Results: The QardioArm fulfilled the ESH-IP2 validation criteria in patients who suffered from chronic kidney disease. Conclusions: Thus, this study is considered as the first validation using a wireless upper arm oscillometric device connected to an app to measure BP and HR meeting the ESH-IP2 requirements in patients who suffer from chronic kidney disease. New validation studies following the ESH-IP2 guidelines should be carried out using different BP devices in patients with specific diseases.es_ES
dc.language.isoenges_ES
dc.publisherJMIR Publicationses_ES
dc.relation.urihttp://dx.doi.org/10.2196/14686es_ES
dc.rightsAtribución 3.0 Españaes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectBlood pressurees_ES
dc.subjectHypertensiones_ES
dc.subjectKidney diseasees_ES
dc.subjectMobile appses_ES
dc.subjectSoftware validationes_ES
dc.titleQardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease : A Validation Study According to the European Society of Hypertension International Protocol Revision 2010es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleJournal of Medical Internet Researches_ES
UDC.volume21es_ES
UDC.issue12es_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record